INTELLECTUAL CAPITAL TERHADAP KINERJA PERUSAHAAN FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA (BEI) PERIODE 2009–2017
Media Akuntansi dan Perpajakan Indonesia · 2020
DOI: 10.37715/mapi.v1i1.1399 ↗Kurz gefasst
Fachartikel in der Zeitschrift Media Akuntansi dan Perpajakan Indonesia, 2020. Verfasst von Christina Agusta und 1 weiteren Autor:innen.
Abstract (Originalsprache)
This purpose of this research is to analyze the impact of intellectualcapital on the companies performance. The research used quantitativeapproach, and it collected by annual reports to pharmaceutical company atIndonesia Stock Exchange (IDX) from year 2009–2017 which had a populationof 10 companies. The hypothesis of this research is tested by usingmultiple regression analysis. The result indicate that (1) intellectual capitalhas positive influence to the companies performance (ROA and ROE); (2)intellectual capital has negative influence on companies performance (ATOand MBV). Hence, to maximize the performance on pharmaceutical companiesmerely consider intellectual capital factors.
Zitieren
APA
Agusta, C., & Radianto, W. E. (2020). INTELLECTUAL CAPITAL TERHADAP KINERJA PERUSAHAAN FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA (BEI) PERIODE 2009–2017. Media Akuntansi dan Perpajakan Indonesia. https://doi.org/10.37715/mapi.v1i1.1399
Vancouver
Agusta C, Radianto WE. INTELLECTUAL CAPITAL TERHADAP KINERJA PERUSAHAAN FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA (BEI) PERIODE 2009–2017. Media Akuntansi dan Perpajakan Indonesia. 2020. doi:10.37715/mapi.v1i1.1399
BibTeX
@article{Agusta2020,
author = {Agusta, Christina and Radianto, Wirawan E.D.},
title = {INTELLECTUAL CAPITAL TERHADAP KINERJA PERUSAHAAN FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA (BEI) PERIODE 2009–2017},
journal = {Media Akuntansi dan Perpajakan Indonesia},
year = {2020},
doi = {10.37715/mapi.v1i1.1399}
}
EUVIMED